LY3526318

LY3526318 · Eli Lilly and Company

Drug timelines are a Plus or Pro feature.

6 regulatory and trial events tracked for LY3526318, covering 2023-09-06 to 2025-10-06. Get the full timeline:

Most recent: Clinical Trial Update: A Study of LY3526318 in Healthy Women [Phase 1]